Abstract:The early life stages are critical for the development of the gut microbiome. Variables such as antibiotics exposure, birth-mode via Cesarean section, and formula feeding are associated with disruptions in microbiome development and are related to adverse health effects later in life. Studying the effects of microbiome-modulating strategies in infants is challenged by appropriate ethical constraints. Therefore, we developed I-TIM-2, an infant in vitro colonic model based on the validated, computer-controlled, dynamic model of the colon, TIM-2. The system, consisting of four separate compartments, was inoculated with feces from four healthy, primarily breastfed infants, displaying distinctive microbiome profiles. For each infant's fecal sample, a 96-h experiment was performed, with two compartments receiving an infant diet adapted medium and two compartments additionally receiving five human milk oligosaccharides (HMOs) in physiological concentrations and proportions. Bacterial composition was determined by shotgun metagenomics and qPCR. Concentrations of short-chain fatty acids (SCFAs) and HMOs were determined by LC-MS. Microbial diversity and high amounts of inoculum-derived species were preserved in the model throughout each experiment. Microbiome composition and SCFA concentrations were consistent with published data from infants. HMOs strongly modulated the microbiome composition by stimulating relative proportions of Bifidobacterium. This affected the metabolic output and resulted in an increased production of acetic and formic acid, characteristic of bifidobacterial HMO metabolism. In conclusion, these data demonstrate the development of a valid model to study the dynamics and modulations of the infant gut microbiome and metabolome.IMPORTANCEThe infant gut microbiome is intricately linked to the health of its host. This is partly mediated through the bacterial production of metabolites that interact with the host cells. Human milk shapes the establishment of the infant gut microbiome as it contains human milk sugars that select for primarily bifidobacteria. The establishment can be disrupted by modern interventions such as formula feeding. This can alter the microbiome composition and metabolite production profile, which can affect the host. In this article, we set up an infant in vitro colonic model to study microbiome interactions and functions. In this model, we investigated the effects of human milk sugars and their promotion of bifidobacteria at the expense of other bacteria. The model is an ideal system to assess the effects of various modulating strategies on the infant gut microbiome and its interactions with its host.

A microfluidic model for infantile in vitro digestions: Characterization of lactoferrin digestion

In vitro dynamic model simulating the digestive tract of 6-month-old infants

A miniaturised semi-dynamic in-vitro model of human digestion

Development of an infant colon simulating in vitro model, I-TIM-2, to study the effects of modulation strategies on the infant gut microbiome composition and function

Can dynamic in vitro digestion systems mimic the physiological reality?

Changes in interfacial composition and structure of milk fat globules are crucial regulating lipid digestion in simulated <i>in</i>-<i>vitro </i>infant gastrointestinal digestion

A miniaturised semi-dynamic model of human digestion

Model infant formulas: Influence of types of whey proteins and lipid composition on the in vitro static digestion behavior

Effects of the Gastric Juice Injection Pattern and Contraction Frequency on the Digestibility of Casein Powder Suspensions in an in Vitro Dynamic Rat Stomach Made with a 3D Printed Model.

Protein structure in model infant milk formulas impacts their kinetics of hydrolysis under in vitro dynamic digestion

Venturing into In Vitro Physiological Upper GI System Focusing on the Motility Effect Provided by a Mechanised Rat Stomach Model

Efficient In Vitro Digestion of Lipids and Proteins in Bovine Milk Fat Globule Membrane (MFGM) Ingredient and Infant Formula Containing MFGM

Dynamic in vitro gastric digestion of skimmed milk using the NERDT, an advanced human biomimetic digestion system

The Smallest Intestine (TSI)-a low volume in vitro model of the small intestine with increased throughput

Exploring species-level infant gut bacterial biodiversity by meta-analysis and formulation of an optimized cultivation medium

Dynamic In Vitro Gastric Digestion Behaviour of Commercial Infant Formulae Made with Cow, Goat and Sheep Milk

Interfacial Composition in Infant Formulas Powder Modulate Lipid Digestion in Simulated In-Vitro Infant Gastrointestinal Digestion

Assessing the In Vitro Digestion of Lactoferrin-Curcumin Nanoparticles Using the Realistic Gastric Model

In Vitro Gut Fermentation of Whey Protein Hydrolysate: An Evaluation of Its Potential Modulation on Infant Gut Microbiome

Simulated in Vitro Infant Digestion and Lipidomic Analysis to Explore How the Milk Fat Globule Membrane Modulates Fat Digestion

Comparison between the digestive behaviors of a new in vitro rat soft stomach model with that of the in vivo experimentation on living rats-Motility and morphological influences